Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA extends review period for Forest Lab lung drug
FDA extends review period for Forest Lab lung drug
FDA extends review period for Forest Lab lung drug
Submitted by
admin
on March 29, 2012 - 12:07pm
Source:
Reuters
News Tags:
COPD
Forest Labs
FDA
Almirall
Headline:
FDA extends review period for Forest Lab lung drug
Do Not Allow Advertisers to Use My Personal information
